Hepatologists in Bengaluru launch "Liver Tech Check" to study digital lifestyle-related liver disease among IT professionals.

A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

There currently are no FDA-approved treatments for SPMS, researchers said in background ... blocking enzymes that promote ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

A preclinical study from scientists at Scripps Research finds that a apremilast, a drug already FDA-approved for treating ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests.

There currently are no FDA-approved treatments for SPMS, researchers said in background notes. Related Fish-rich diet ... These drugs work by blocking enzymes that promote cell growth and division.

Humans have come a long way as the most dominant species on Earth, largely due to sophisticated adaptations, ingenuity, and ...

Mineralys plans to provide additional data from the pivotal Phase 3 Launch-HTN at an upcoming medical conference and in a peer-reviewed publication. Additionally, the ongoing Transform-HTN open-label ...

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.